Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2018-01-31
DOI
10.1080/0284186x.2018.1433323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cisplatin is retained in the cochlea indefinitely following chemotherapy
- (2017) Andrew M. Breglio et al. Nature Communications
- Variants inWFS1and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
- (2016) Heather E. Wheeler et al. CLINICAL CANCER RESEARCH
- Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria
- (2016) Sofia Waissbluth et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- The Sound of Silence: A Proxy for Platinum Toxicity
- (2016) Jan Oldenburg et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
- (2016) Robert D. Frisina et al. JOURNAL OF CLINICAL ONCOLOGY
- Early ototoxic changes in patients with germ cell tumor after first cycle of cisplatin-based therapy
- (2016) László Noszek et al. LARYNGOSCOPE
- Prevalence of age-related hearing loss, including sex differences, in older adults in a large cohort study
- (2016) Nienke C. Homans et al. LARYNGOSCOPE
- Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
- (2016) Line V. Hjelle et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling
- (2015) A R Fetoni et al. BRITISH JOURNAL OF CANCER
- Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma
- (2014) James G. Gurney et al. NEURO-ONCOLOGY
- Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data
- (2013) Charlotte Le Cornet et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
- (2012) Jochen Schacht et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up
- (2012) Hege S. Haugnes et al. JOURNAL OF CLINICAL ONCOLOGY
- Occupation and the risk of bothersome tinnitus: results from a prospective cohort study (HUNT)
- (2012) Bo Engdahl et al. BMJ Open
- Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer
- (2011) Mette Sprauten et al. JOURNAL OF CLINICAL ONCOLOGY
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors
- (2009) M. Brydoy et al. JNCI-Journal of the National Cancer Institute
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- Medical Treatment of Advanced Testicular Cancer
- (2008) Darren R. Feldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now